Asset Allocation

As of March 31, 2026.
Type % Net
Cash 0.75%
Stock 98.40%
Bond 1.10%
Convertible 0.00%
Preferred 0.01%
Other -0.25%
View Asset Allocation
Start Trial

Market Capitalization

As of March 31, 2026
Large 63.05%
Mid 18.21%
Small 18.74%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 99.23%    % Emerging Markets: 0.00%    % Unidentified Markets: 0.77%

Americas 77.92%
77.92%
Canada 0.57%
United States 77.35%
0.00%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 21.31%
United Kingdom 7.09%
14.22%
Germany 3.24%
Ireland 7.71%
Netherlands 3.27%
0.00%
0.00%
Greater Asia 0.00%
Japan 0.00%
0.00%
0.00%
0.00%
Unidentified Region 0.77%

Stock Sector Exposure

Cyclical
18.96%
Materials
5.02%
Consumer Discretionary
9.65%
Financials
0.00%
Real Estate
4.30%
Sensitive
72.07%
Communication Services
0.00%
Energy
0.78%
Industrials
43.91%
Information Technology
27.38%
Defensive
6.84%
Consumer Staples
0.00%
Health Care
0.00%
Utilities
6.84%
Not Classified
2.13%
Non Classified Equity
0.29%
Not Classified - Non Equity
1.84%
As of March 31, 2026
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available